Changfa Xia

7.3k total citations · 4 hit papers
94 papers, 3.5k citations indexed

About

Changfa Xia is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changfa Xia has authored 94 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 35 papers in Epidemiology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changfa Xia's work include Global Cancer Incidence and Screening (41 papers), Colorectal Cancer Screening and Detection (29 papers) and Gastric Cancer Management and Outcomes (14 papers). Changfa Xia is often cited by papers focused on Global Cancer Incidence and Screening (41 papers), Colorectal Cancer Screening and Detection (29 papers) and Gastric Cancer Management and Outcomes (14 papers). Changfa Xia collaborates with scholars based in China, United States and Australia. Changfa Xia's co-authors include Wanqing Chen, Rongshou Zheng, Hongmei Zeng, Siwei Zhang, Zhixun Yang, Xiaonong Zou, Kexin Sun, Tingting Zuo, Li He and Jie He and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Changfa Xia

82 papers receiving 3.4k citations

Hit Papers

Cancer incidence and mortality in China, 2014 2017 2026 2020 2023 2018 2017 2022 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer incidence and mortality in China, 2014
    2018 766 citations Wanqing Chen, Rongshou Zheng et al. Chinese Journal of Cancer Research profile →
  2. Cancer incidence and mortality in China, 2013
    2017 360 citations Wanqing Chen, Rongshou Zheng et al. Cancer Letters profile →
  3. Current cancer burden in China: epidemiology, etiology, and prevention
    2022 171 citations Maomao Cao, He Li et al. Cancer Biology and Medicine profile →
  4. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
    2023 105 citations Siyi He, Changfa Xia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changfa Xia China 25 1.3k 1.0k 813 741 684 94 3.5k
Kexin Sun China 16 1.2k 0.9× 747 0.7× 738 0.9× 583 0.8× 514 0.8× 27 2.9k
Greta Carioli Italy 25 1.6k 1.2× 700 0.7× 717 0.9× 625 0.8× 713 1.0× 62 3.3k
Kexin Sun China 24 1.3k 1.0× 1.0k 1.0× 874 1.1× 623 0.8× 586 0.9× 85 3.9k
Yi Zheng China 29 941 0.7× 1.2k 1.2× 695 0.9× 795 1.1× 433 0.6× 134 3.5k
Xiaonong Zou China 27 1.6k 1.2× 1.4k 1.3× 1.0k 1.3× 963 1.3× 800 1.2× 54 4.4k
Andrew Lake United States 7 1.5k 1.1× 768 0.8× 782 1.0× 736 1.0× 297 0.4× 15 3.3k
Shaoming Wang China 12 1.3k 1.0× 847 0.8× 815 1.0× 533 0.7× 539 0.8× 21 3.2k
Jiansong Ren China 24 1.3k 1.0× 743 0.7× 835 1.0× 508 0.7× 840 1.2× 91 3.4k
Deborah Mukherji Lebanon 30 1.4k 1.0× 1.2k 1.2× 896 1.1× 652 0.9× 476 0.7× 183 3.4k
Jing Jiang China 37 1.1k 0.9× 1.2k 1.2× 919 1.1× 1.3k 1.8× 1.1k 1.6× 160 4.5k

Countries citing papers authored by Changfa Xia

Since Specialization
Citations

This map shows the geographic impact of Changfa Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changfa Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changfa Xia more than expected).

Fields of papers citing papers by Changfa Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changfa Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changfa Xia. The network helps show where Changfa Xia may publish in the future.

Co-authorship network of co-authors of Changfa Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Changfa Xia. A scholar is included among the top collaborators of Changfa Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changfa Xia. Changfa Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Changfa, Ruonan Liu, Shujing Zhang, Jilu Shen, & Zhongxin Wang. (2025). Fluconazole-induced changes in azole resistance and biofilm production in Candida glabrata in vitro. Diagnostic Microbiology and Infectious Disease. 111(3). 116683–116683. 2 indexed citations
2.
3.
4.
5.
6.
Wang, Xinyue, Changfa Xia, Yong-Wen Song, et al.. (2024). Multicenter Phase Ii Study of Moderate Low-Dose Radiotherapy in Indolent Non-Hodgkin Lymphoma: CLCG-iNHL-01 Protocol. Future Oncology. 20(2). 71–81. 2 indexed citations
7.
Xia, Changfa, Yongjie Xu, Li He, Siyi He, & Wanqing Chen. (2024). Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysis. The Lancet Regional Health - Western Pacific. 44. 101012–101012. 8 indexed citations
8.
Zhao, Xuelian, Shuang Zhao, Changfa Xia, et al.. (2023). Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study. BMC Medicine. 21(1). 149–149. 6 indexed citations
9.
Yang, Fan, Dianqin Sun, Chao Ding, et al.. (2023). Global patterns of cancer transitions: A modelling study. International Journal of Cancer. 153(9). 1612–1622. 3 indexed citations
10.
He, Siyi, Maomao Cao, Dianqin Sun, et al.. (2023). Geographic, Demographic, and Socioeconomic Disparities and Factors Associated With Cancer Literacy in China: National Cross-sectional Study. JMIR Public Health and Surveillance. 9. e43541–e43541. 10 indexed citations
11.
Teng, Yi, Xinxin Yan, Maomao Cao, et al.. (2023). Profiles and Findings of Population-Based Esophageal Cancer Screening With Endoscopy in China: Systematic Review and Meta-analysis. JMIR Public Health and Surveillance. 9. e45360–e45360. 6 indexed citations
12.
Zeng, Hongmei, Sergiusz Nawrocki, Jakub Morze, et al.. (2023). Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study. EClinicalMedicine. 62. 102138–102138. 17 indexed citations
13.
Cao, Maomao, He Li, Dianqin Sun, et al.. (2022). Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biology and Medicine. 19(8). 1121–1138. 171 indexed citations breakdown →
14.
15.
Xia, Changfa & Wanqing Chen. (2022). The NCC mathematical modeling framework for decision-making of six major cancers. SHILAP Revista de lepidopterología. 3(1). 35–47. 2 indexed citations
16.
Cao, Maomao, Lingling Lu, Chunsun Fan, et al.. (2022). Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 years. Cancer Letters. 536. 215652–215652. 21 indexed citations
17.
Li, Qianru, Maomao Cao, Siyi He, et al.. (2022). Colorectal cancer burden, trends and risk factors in China: A review and comparison with the United States. Chinese Journal of Cancer Research. 34(5). 483–495. 26 indexed citations
18.
Liao, Yilan, Chunlin Li, Changfa Xia, et al.. (2020). Spatial distribution of esophageal cancer mortality in China: a machine learning approach. International Health. 13(1). 70–79. 8 indexed citations
19.
Chen, Wanqing, Rongshou Zheng, Siwei Zhang, et al.. (2017). Cancer incidence and mortality in China, 2013. Cancer Letters. 401. 63–71. 360 indexed citations breakdown →
20.
Zuo, Tingting, Hongmei Zeng, Huichao Li, et al.. (2017). The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study. Chinese Journal of Cancer. 36(1). 84–84. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kexin Sun Breakdown of academic impact, for papers by Greta Carioli Breakdown of academic impact, for papers by Kexin Sun Breakdown of academic impact, for papers by Yi Zheng Breakdown of academic impact, for papers by Xiaonong Zou Breakdown of academic impact, for papers by Andrew Lake Breakdown of academic impact, for papers by Shaoming Wang Breakdown of academic impact, for papers by Jiansong Ren Breakdown of academic impact, for papers by Deborah Mukherji Breakdown of academic impact, for papers by Jing Jiang
Rankless by CCL
2026